Literature DB >> 15001819

Antinociceptive effects of peripheral benzodiazepine receptors.

Silvia DalBó1, Geisson M Nardi, Pascual Ferrara, Rosa M Ribeiro-do-Valle, Roseli C Farges.   

Abstract

Pretreatment of mice with Ro5-4864 or PK11195 inhibited the first- and second-phase responses in the formalin test and this effect was significantly reversed by aminoglutethimide, an inhibitor of pregnenolone synthesis, suggesting that the antinociceptive effect of the peripheral-type benzodiazepine receptor ligands is dependent on steroid formation. Doses of Ro5-4864 that did not produce an antinociceptive effect when injected by the intraperitoneal route presented an analgesic effect, if infected by the intracerebroventricular, intrathecal or intraplantar routes. PK11195 pretreatments with intrathecal, intracerebroventricular or intraplantar doses had no effect in the formalin test. These results suggest that the antinociceptive effect of Ro5-4864 reflects the influence of this ligand on steroid production not only in many nonneuronal peripheral tissues but also in the nervous system, while the antinociceptive action of PK11195 may be due to the stimulation of steroid synthesis only in nonnervous tissues. Copyright 2004 S. Karger AG, Basel

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15001819     DOI: 10.1159/000075547

Source DB:  PubMed          Journal:  Pharmacology        ISSN: 0031-7012            Impact factor:   2.547


  9 in total

Review 1.  Fast nongenomic effects of steroids on synaptic transmission and role of endogenous neurosteroids in spinal pain pathways.

Authors:  Rémy Schlichter; Anne Florence Keller; Mathias De Roo; Jean-Didier Breton; Perrine Inquimbert; Pierrick Poisbeau
Journal:  J Mol Neurosci       Date:  2006       Impact factor: 3.444

2.  Effect of adjuvant drugs on the action of local anesthetics in isolated rat sciatic nerves.

Authors:  Eser Yilmaz-Rastoder; Michael S Gold; Karen A Hough; G F Gebhart; Brian A Williams
Journal:  Reg Anesth Pain Med       Date:  2012 Jul-Aug       Impact factor: 6.288

3.  Inflammation-induced shift in the valence of spinal GABA-A receptor-mediated modulation of nociception in the adult rat.

Authors:  Vanessa C Z Anseloni; Michael S Gold
Journal:  J Pain       Date:  2008-05-07       Impact factor: 5.820

4.  Spinal translocator protein (TSPO) modulates pain behavior in rats with CFA-induced monoarthritis.

Authors:  Hayley Hernstadt; Shuxing Wang; Grewo Lim; Jianren Mao
Journal:  Brain Res       Date:  2009-06-23       Impact factor: 3.252

5.  Anxiolytic-like effects of translocator protein (TSPO) ligand ZBD-2 in an animal model of chronic pain.

Authors:  Dong-Sheng Wang; Zhen Tian; Yan-Yan Guo; Hong-Liang Guo; Wen-Bo Kang; Shuo Li; Ya-Ting Den; Xu-Bo Li; Bing Feng; Dan Feng; Jian-Ning Zhao; Gang Liu; Ming-Gao Zhao
Journal:  Mol Pain       Date:  2015-03-26       Impact factor: 3.395

Review 6.  'New/Designer Benzodiazepines': An Analysis of the Literature and Psychonauts' Trip Reports.

Authors:  Laura Orsolini; John M Corkery; Stefania Chiappini; Amira Guirguis; Alessandro Vento; Domenico De Berardis; Duccio Papanti; Fabrizio Schifano
Journal:  Curr Neuropharmacol       Date:  2020       Impact factor: 7.363

Review 7.  Translocator Protein 18 kDa (TSPO) as a Novel Therapeutic Target for Chronic Pain.

Authors:  Jie Liu; Jingyao Huang; Zhenjiang Zhang; Rui Zhang; Zhihao Zhang; Yongxin Liu; Baoyu Ma
Journal:  Neural Plast       Date:  2022-08-29       Impact factor: 3.144

8.  Identification of Koumine as a Translocator Protein 18 kDa Positive Allosteric Modulator for the Treatment of Inflammatory and Neuropathic Pain.

Authors:  Bojun Xiong; Guilin Jin; Ying Xu; Wenbing You; Yufei Luo; Menghan Fang; Bing Chen; Huihui Huang; Jian Yang; Xu Lin; Changxi Yu
Journal:  Front Pharmacol       Date:  2021-06-24       Impact factor: 5.810

9.  Analgesic effects and pharmacologic mechanisms of the Gelsemium alkaloid koumine on a rat model of postoperative pain.

Authors:  Bo-Jun Xiong; Ying Xu; Gui-Lin Jin; Ming Liu; Jian Yang; Chang-Xi Yu
Journal:  Sci Rep       Date:  2017-10-27       Impact factor: 4.379

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.